Cystic Fibrosis Transmembrane Conductance Regulator Mutation Spectrum in Patients with Cystic Fibrosis in Tunisia

被引:27
作者
Fredj, Sondess Hadj [1 ]
Messaoud, Taieb [1 ]
Templin, Carine [2 ]
des Georges, Marie [2 ,3 ]
Fattoum, Slaheddine [1 ]
Claustres, Mireille [2 ,3 ,4 ]
机构
[1] Hop Enfants Tunis, Lab Biochim & Biol Mol, Tunis, Tunisia
[2] Hop Arnaud Villeneuve, CHU Montpellier, Mol Genet Lab, F-34000 Montpellier, France
[3] INSERM, U827, F-34000 Montpellier, France
[4] Univ Montpellier, UFR Med, Mol Genet Lab, F-34000 Montpellier, France
关键词
CFTR GENE; MOLECULAR CHARACTERIZATION; IDENTIFICATION; DISEASE; FRANCE; REGION; DNA;
D O I
10.1089/gtmb.2009.0028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aim: To determine the frequency and types of mutations causing cystic fibrosis (CF) in Tunisia. Methods: We analyzed the complete coding region and flanking intronic sequences of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in 68 unrelated patients suffering from the classical form of the disease. Results: Twelve different CFTR mutations accounted for 90% (123/136) of CF alleles, including F508del (47.06%), E1104X (16.18%), N1303K (6.62%), 711 + 1T> G (5.88%), W1282X (4.41%), G542X (3.67%), R1158X (1.47%), 4016insT (0.74%), and R785X (0.74%). Three novel mutations were detected in this study: I1203V (1.47%), 1811 + 5A > G (0.74%), and 4268 + 2T > G (1.47%). Fifty patients (74%) were homozygous, among which 28 (41.17%) for F508del and 10 (14.7%) for E1104X. Conclusions: Ninety-seven percent of patients were found with at least one CFTR mutation. This study contributes to a better knowledge on CF-causing mutations in different regions in Tunisia and demonstrates that a complete scanning of CFTR sequences is necessary to implement efficient programs for CF genetic screening and counseling in this part of North Africa.
引用
收藏
页码:577 / 581
页数:5
相关论文
共 21 条
[1]   Analysis of the CFTR gene in Iranian cystic fibrosis patients: Identification of eight novel mutations [J].
Alibakhshi, Reza ;
Kianishirazi, Roya ;
Cassiman, Jean-Jacques ;
Zamani, Mahdi ;
Cuppens, Harry .
JOURNAL OF CYSTIC FIBROSIS, 2008, 7 (02) :102-109
[2]   Cystic fibrosis: A worldwide analysis of CFTR mutations - Correlation with incidence data and application to screening [J].
Bobadilla, JL ;
Macek, M ;
Fine, JP ;
Farrell, PM .
HUMAN MUTATION, 2002, 19 (06) :575-606
[3]  
Claustres M, 2000, HUM MUTAT, V16, P143, DOI 10.1002/1098-1004(200008)16:2<143::AID-HUMU7>3.0.CO
[4]  
2-J
[5]  
CLAUSTRES M, 1992, HUM GENET, V90, P464
[6]   WGA Allows the Molecular Characterization of a Novel Large CFTR Rearrangement in a Black South African Cystic Fibrosis Patient [J].
des Georges, Marie ;
Guittard, Caroline ;
Templin, Carine ;
Altieri, Jean-Pierre ;
de Carvalho, Candice ;
Ramsay, Michele ;
Claustres, Mireille .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06) :544-548
[7]   MOLECULAR CHARACTERIZATION OF CYSTIC-FIBROSIS - 16 NOVEL MUTATIONS IDENTIFIED BY ANALYSIS OF THE WHOLE CYSTIC-FIBROSIS CONDUCTANCE TRANSMEMBRANE REGULATOR (CFTR) CODING REGIONS AND SPLICE SITE JUNCTIONS [J].
FANEN, P ;
GHANEM, N ;
VIDAUD, M ;
BESMOND, C ;
MARTIN, J ;
COSTES, B ;
PLASSA, F ;
GOOSSENS, M .
GENOMICS, 1992, 13 (03) :770-776
[8]   A NOVEL MUTATION IN THE CYSTIC-FIBROSIS GENE IN PATIENTS WITH PULMONARY-DISEASE BUT NORMAL SWEAT CHLORIDE CONCENTRATIONS [J].
HIGHSMITH, WE ;
BURCH, LH ;
ZHOU, ZQ ;
OLSEN, JC ;
BOAT, TE ;
SPOCK, A ;
GORVOY, JD ;
QUITTELL, L ;
FRIEDMAN, KJ ;
SILVERMAN, LM ;
BOUCHER, RC ;
KNOWLES, MR .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (15) :974-980
[9]   CFTR mutations in Turkish and north African cystic fibrosis patients in Europe:: Implications for screening [J].
Lakeman, Phillis ;
Gille, Johan J. P. ;
Dankert-Roelse, Jeannette E. ;
Heijerman, Harry G. M. ;
Munck, Anne ;
Iron, Albert ;
Grasemann, Hartmut ;
Schuster, Antje ;
Cornel, Martina C. ;
ten Kate, Leo P. .
GENETIC TESTING, 2008, 12 (01) :25-35
[10]   Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC):: major implications for genetic counselling [J].
Le Maréchal, C ;
Audrézet, MP ;
Quéré, I ;
Raguénès, O ;
Langonné, S ;
Férec, C .
HUMAN GENETICS, 2001, 108 (04) :290-298